COLLPLANT BIOTECH. IS-01 (CPT) — Cash Flow Reinvestment Rate

Latest as of December 2021: 12.63x

COLLPLANT BIOTECH. IS-01 (CPT) has a Cash Flow Reinvestment Rate of 12.63x as of December 2021, reinvesting €31.59 Million (capex €1.59 Million plus investments €-30.00 Million) from operating cash flow of €2.50 Million. See COLLPLANT BIOTECH. IS-01 (CPT) FCF generation index to measure how efficiently the company converts operating cash flow to free cash.

Reinvestment Rate

12.63x

(Capex + Investments) / Operating CF

Total Reinvested

€31.59 Million

Capex + Investments

Operating Cash Flow

€2.50 Million

EUR

Capital Expenditures

€1.59 Million

EUR

COLLPLANT BIOTECH. IS-01 Cash Flow Reinvestment Rate (2021–2021)

Historical reinvestment intensity for COLLPLANT BIOTECH. IS-01 across 1 annual periods. For the full cash flow conversion analysis, see COLLPLANT BIOTECH. IS-01 (CPT) cash conversion ratio.

Annual Cash Flow Reinvestment Rate for COLLPLANT BIOTECH. IS-01 (2021–2021)

Year-by-year capital reinvestment analysis for COLLPLANT BIOTECH. IS-01. See CPT free cash flow debt coverage to measure the company's free cash flow as a share of total liabilities.

Year	Reinvestment Rate	Total Reinvested (EUR)	Operating CF	Capex	YoY Change
2021	12.63x	€31.59 Million	€2.50 Million	€1.59 Million	—

Cash Flow Reinvestment Rate = (ABS(Capex) + ABS(Investments)) / Operating Cash Flow